By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...

Regeneron Pharmaceuticals gains FDA approval for Lynozyfic drug targeting multiple myeloma, with launch details and executive ...

The U.S. Food and Drug Administration has approved Regeneron Pharmaceuticals' Lynozyfic, a therapy for recurrent multiple myeloma, boosting the company's shares by 2%.

A Senedd member has called for a greater focus on veterans diagnosed with cancer amid concerns about a causal link to exposure to toxic fumes ...

With Oklahoma’s rate of diabetes and other metabolic disorders climbing ever higher, it was surprising to many in June when Norman Regional Hospital announced the closure of its Endocrine Para/Thyroid ...

Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...

From July 26-27, over a thousand cyclists will converge in Mequon, Wisconsin, to participate in the 33rd Annual Scenic Shore ...

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

The hard work put into that rink eventually led to Nolan’s storied hockey career as both a player and a coach. For the ...